You are reading a NORD Rare Disease Report Abstract. NORD’s full collection of reports on over 1200 rare diseases is available to subscribers (click here for details). We are now also offering two full rare disease reports per day to visitors on our Web site.
NORD is very grateful to David Brouch, NORD Intern from the University of Notre Dame, and Blanche P Alter, MD, MPH, FAAP, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, for assistance in the preparation of this report.
Synonyms of Fanconi Anemia
- Aplastic Anemia with Congenital Anomalies
- Congenital Pancytopenia
- Constitutional Aplastic Anemia
- Fanconi Pancytopenia
- Fanconi Panmyelopathy
- Fanconi's Anemia, Estren-Dameshek Variant
- Fanconi's Anemia, Type I (FA1)
- Fanconi's Anemia, Complementation Group A (FANCA); FAA
- Fanconi's Anemia, Complementation Group B (FANCB); FACB
- Fanconi's Anemia, Complementation Group C (FANCC); FAC
- Fanconi's Anemia, Complementation Group D (FANCD); FACD
- Fanconi's Anemia, Complementation Group E (FANCE); FACE
- Fanconi's Anemia, Complementation Group F (FANF); FACF
- Fanconi's Anemia, Complementation Group G (FANG); FACG
- Fanconi's Anemia, Complementation Group H (FANH); FACH
Fanconi anemia (FA) is a rare genetic disorder, in the category of inherited bone marrow failure syndromes. Half the patients are diagnosed prior to age 10, while about 10 % are diagnosed as adults. Early diagnoses are facilitated in patients with birth defects, such as small size, abnormal thumbs and/or radial bones, skin pigmentation, small heads, small eyes, abnormal kidney structures, and cardiac and skeletal anomalies. The disorder is often associated with a progressive deficiency of all bone marrow production of blood cells, red blood cells, white blood cells, and platelets. Affected individuals have an increased risk of developing a cancer of blood-forming cells in the bone marrow called acute myeloid leukemia (AML), or tumors of the head, neck, skin, gastrointestinal system, or genital tract. FA occurs equally in males and females, and is found in all ethnic groups. It is usually inherited as an autosomal recessive genetic disorder, but X-linked inheritance has also been reported.
There are several subtypes of FA that result from the inheritance of two gene mutations in each of 15 different genes. Most of the subtypes share the characteristic symptoms and findings.
FA is not related to the same as Fanconi syndrome, a rare kidney functional disorder.
Fanconi Anemia Resources
NORD Member Organizations:
(To become a member of NORD, an organization must meet established criteria and be approved by the NORD Board of Directors.)
The information in NORD’s Rare Disease Database is for educational purposes only. It should never be used for diagnostic or treatment purposes. If you have questions regarding a medical condition, always seek the advice of your physician or other qualified health professional. NORD’s reports provide a brief overview of rare diseases. For more specific information, we encourage you to contact your personal physician or the agencies listed as “Resources” on this report.
The National Organization for Rare Disorders (NORD) web site, its databases, and the contents thereof are copyrighted by NORD. No part of the NORD web site, databases, or the contents may be copied in any way, including but not limited to the following: electronically downloading, storing in a retrieval system, or redistributing for any commercial purposes without the express written permission of NORD. Permission is hereby granted to print one hard copy of the information on an individual disease for your personal use, provided that such content is in no way modified, and the credit for the source (NORD) and NORD’s copyright notice are included on the printed copy. Any other electronic reproduction or other printed versions is strictly prohibited.
Copyright 1986, 2989, 1991, 1992, 1993, 1994, 1996, 1997, 1998, 1999, 2006, 2007, 2009, 2013
NORD's Rare Disease Information Database is copyrighted and may not be published without the written consent of NORD.